Barnett, Christopher F <br/><br/>
Treatment of sarcoidosis-associated pulmonary hypertension. A two-center experience.  [electronic resource] 

 -  Chest  Jun 2009 
 - 1455-1461 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, N.I.H., Intramural 
<br/><br/><label>ISSN: </label>1931-3543 
<br/><br/><label>Standard No.: </label>10.1378/chest.08-1881  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Inhalation<br/>Administration, Oral<br/>Aged<br/>Antihypertensive Agents--administration & dosage<br/>Bosentan<br/>Cohort Studies<br/>Drug Therapy, Combination<br/>Epoprostenol--administration & dosage<br/>Female<br/>Follow-Up Studies<br/>Hemodynamics--drug effects<br/>Humans<br/>Hypertension, Pulmonary--drug therapy<br/>Iloprost--administration & dosage<br/>Kaplan-Meier Estimate<br/>Linear Models<br/>Male<br/>Middle Aged<br/>Piperazines--administration & dosage<br/>Probability<br/>Purines--administration & dosage<br/>Respiratory Function Tests<br/>Retrospective Studies<br/>Risk Assessment<br/>Sarcoidosis--complications<br/>Severity of Illness Index<br/>Sildenafil Citrate<br/>Statistics, Nonparametric<br/>Sulfonamides--administration & dosage<br/>Sulfones--administration & dosage<br/>Survival Rate<br/>Treatment Outcome